Battery technology company Novonix has raised $32.3 million in a heavily-oversubscribed share purchase plan for eligible retail shareholders.

Neuren Pharmaceuticals' Rett syndrome treatment, trofinetide, is a step closer to receiving regulatory approval in the ...

Telstra and Accenture have agreed to a proposed joint venture to accelerate Telstra's data and artificial intelligence ...

New Zealand dairy giant Fonterra is set to delist from the ASX next month after receiving the nod from the bourse operator.

UBS has upgraded its rating on Guzman y Gomez, spurred by increased confidence in the Mexican food chain's same-store sales ...

The Albanese government's National Reconstruction Fund Corporation (NRFC) has agreed a $200 million cornerstone investment in ...

The Australian sharemarket is set to open lower after choppy trading on Wall Street, where investors braced for key inflation ...

The news: Yancoal chief executive David Moult has resigned after seven years at the coal miner. The numbers: Moult spent five ...

Plus: JPM’s Jamie Dimon heir battle takes a turn; US inflation surprises as PPI climbs just 0.2%; SpaceX debris delays Qantas ...

A copy of the communications minister's diary obtained by Capital Brief shows the codes were among the last stakeholders to secure meetings before Labor shelved plans to restrict gambling ads.

Software company Oracle is continuing its effort to pause a local court battle with the Commissioner of Taxation, with implications for other companies with cross-border software distribution ...

The biggest activist fund in Australia explains its latest bet on a struggling legacy media giant and why ASX boards should expect more shareholder pressure.